Epizódjegyzetek
Huge genetic databases. Drug ingredient supply chains. A next pandemic. War with Taiwan. Economic competition. A huge number of topics and scenarios get lumped into the "China biosecurity" conversation — some present and real, some far-fetched and far-off. So what are we really talking about when we talk about China and bio-risk? What deserves the attention and policy action? Which ones are fear-mongering? Live from Endpoints’ China Biotech Debate: Washington, DC on September 15, 2026.
Weboldal: podcasters.spotify.com

